Research and Development (R&D) Expenses: R&D expenses were $26.6 million for the three months ended March 31, 2025, compared to $23.4 million for the same period in 2024. The increase in R&D expenses ...

Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ETCompany ParticipantsSiting Li - IR DirectorStanley Peng - ...

Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome ...

Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...

Additionally, prolonged inflammation changes the tissue microenvironment ... Head and neck cancers, particularly those affecting the oral cavity, pharynx, and esophagus, naturally show the ...

In fact, there are a number of entirely pragmatic reasons to conclude that prioritizing human factors is simply a good business strategy. In this article, we review the value of human factors ...

Welcome to Zymeworks first-quarter 2025 results conference call and webcast. (Operator Instructions) I would now like to turn the conference over to Shrinal Inamdar, Senior Director of Investor ...

Inovio Pharmaceuticals, Inc. ( NASDAQ: INO) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical Officer Steve Egge - ...

Lauren Hirsch covers Wall Street for The Times, including M&A, executive changes, board strife and policy moves affecting business. Edmund Lee covers the media industry as it grapples with changes ...

consumers now report unprecedented levels of uncertainty amid often-changing headlines about how Trump’s tariffs plan may be affecting businesses’ bottom lines. “Tariffs are now on top of ...

Disclaimer: This Working Paper should not be reported as representing the views of the IMF.The views expressed in this Working Paper are those of the author(s) and do not necessarily represent those ...